Statistics from Altmetric.com
Ghonim MA, Ibba SV, Tarhuni AF, et al. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J Immunotherapy Cancer 2021;9:e001643. doi: 10.1136/jitc-2020-001643
This paper has been updated to revise author affiliations and funding details.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.